(VIANEWS) – Simulations Plus (SLP), Century Communities (CCS), Microsoft (MSFT) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Simulations Plus (SLP)
38.9% sales growth and 5.51% return on equity
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for noncompartmental analysis and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher. In addition, it offers KIWI, a cloud-based web application to organize, process, maintain, and communicate the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program; DILIsym, a quantitative systems pharmacology software; NAFLDsym, a simulation program for analyzing nonalcoholic fatty liver disease; RENAsym for investigating and predicting drug-induced or acute kidney injury; IPFsym, a software tool to treat or cure idiopathic pulmonary fibrosis; and the Monolix Suite, a solution for modeling and simulation. Further, the company provides population modeling and simulation contract research services; and clinical-pharmacology-based consulting services in support of regulatory submissions. It serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. The company was founded in 1996 and is headquartered in Lancaster, California.
Earnings Per Share
As for profitability, Simulations Plus has a trailing twelve months EPS of $0.48.
PE Ratio
Simulations Plus has a trailing twelve months price to earnings ratio of 83.83. Meaning, the purchaser of the share is investing $83.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.51%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 14.2%, now sitting on 66.98M for the twelve trailing months.
Sales Growth
Simulations Plus’s sales growth is 26.3% for the current quarter and 38.9% for the next.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 50% and a drop 30% for the next.
2. Century Communities (CCS)
31.1% sales growth and 12.64% return on equity
Century Communities, Inc., together with its subsidiaries, engages in the design, development, construction, marketing, and sale of single-family attached and detached homes. It is also involved in the entitlement and development of the underlying land; and provision of mortgage, title, and insurance services to its home buyers. The company offers homes under the Century Communities and Century Complete brands. It sells homes through its sales representatives, as well as through independent real estate brokers in 17 states in the United States. Century Communities, Inc. was founded in 2002 and is headquartered in Greenwood Village, Colorado.
Earnings Per Share
As for profitability, Century Communities has a trailing twelve months EPS of $9.01.
PE Ratio
Century Communities has a trailing twelve months price to earnings ratio of 10.62. Meaning, the purchaser of the share is investing $10.62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.64%.
Sales Growth
Century Communities’s sales growth is 22.3% for the ongoing quarter and 31.1% for the next.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 29, 2024, the estimated forward annual dividend rate is 1.04 and the estimated forward annual dividend yield is 1.09%.
Yearly Top and Bottom Value
Century Communities’s stock is valued at $95.67 at 01:22 EST, under its 52-week high of $101.50 and way higher than its 52-week low of $58.01.
3. Microsoft (MSFT)
20.9% sales growth and 38.49% return on equity
Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. This segment also provides LinkedIn; and dynamics business solutions, including Dynamics 365, a set of intelligent, cloud-based applications across ERP, CRM, power apps, and power automate; and on-premises ERP and CRM applications. The Intelligent Cloud segment offers server products and cloud services, such as azure and other cloud services; SQL and windows server, visual studio, system center, and related client access licenses, as well as nuance and GitHub; and enterprise services including enterprise support services, industry solutions, and nuance professional services. The More Personal Computing segment offers Windows, including windows OEM licensing and other non-volume licensing of the Windows operating system; Windows commercial comprising volume licensing of the Windows operating system, windows cloud services, and other Windows commercial offerings; patent licensing; and windows Internet of Things; and devices, such as surface, HoloLens, and PC accessories. Additionally, this segment provides gaming, which includes Xbox hardware and content, and first- and third-party content; Xbox game pass and other subscriptions, cloud gaming, advertising, third-party disc royalties, and other cloud services; and search and news advertising, which includes Bing, Microsoft News and Edge, and third-party affiliates. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online, and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.
Earnings Per Share
As for profitability, Microsoft has a trailing twelve months EPS of $11.04.
PE Ratio
Microsoft has a trailing twelve months price to earnings ratio of 38.22. Meaning, the purchaser of the share is investing $38.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 38.49%.
Yearly Top and Bottom Value
Microsoft’s stock is valued at $421.90 at 01:22 EST, under its 52-week high of $468.35 and way above its 52-week low of $309.45.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 0.4% and 7%, respectively.
Moving Average
Microsoft’s value is under its 50-day moving average of $439.07 and above its 200-day moving average of $401.61.
Revenue Growth
Year-on-year quarterly revenue growth grew by 17%, now sitting on 236.58B for the twelve trailing months.
Previous days news about Microsoft(MSFT)
- Zacks earnings trends highlights: Microsoft, Alphabet and Tesla. According to Zacks on Thursday, 1 August, "The sell-off in Alphabet and Microsoft shares is far more challenging to understand, as both of the Tech giants handily beat estimates and showed broadly positive trends in all of their businesses.", "The issue with Microsoft appears to be the seeming deceleration in the company’s Azure unit. "
- According to FXStreet on Friday, 2 August, "NVIDIA also got good news from Microsoft (NASDAQ: MSFT), as the company reported Wednesday that it is increasing its investments in AI infrastructure. ", "With its semiconductor rival AMD (NASDAQ: AMD) posting strong Q2 numbers already, and the projections from Microsoft and Meta to increase its AI spending, NVIDIA should have another huge quarter."
- According to Zacks on Wednesday, 31 July, "This contrasted with the companies’ Q1 releases when Alphabet and Tesla were up big on the quarterly results while Microsoft was only modestly down.", "The sell-off in Alphabet and Microsoft shares is far more challenging to understand, as both of the Tech giants handily beat estimates and showed broadly positive trends in all of their businesses."
- According to Zacks on Thursday, 1 August, "Most of the fund’s holdings were in companies like QUALCOMM Inc (2.7%), Exxon Mobil Corp (2.5%) and Microsoft Corp (2.3%) as of Mar 31, 2024.", "Most of the fund’s holdings were in companies like Microsoft Corp (9%), Amazon.com, Inc. (7.4%) and Alphabet Inc. (5%) as of Mar 31, 2024."
4. Lantheus Holdings (LNTH)
20.1% sales growth and 66.21% return on equity
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. The company also offers Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; and PYLARIFY AI, an AI-based medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer. In addition, it develops 1095, a PSMA-targeted iodine-131-labeled small molecule; PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent that targets Tau tangles in Alzheimer's disease; LNTH-1363S, an fibroblast activation protein, alpha targeted, copper-64 labeled PET imaging agent; and flurpiridaz used to assess blood flow to the heart;. It has collaboration agreements with GE Healthcare; NanoMab Technology Limited; Curium; RefleXion Medical, Inc.; POINT; Regeneron Pharmaceuticals, Inc; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.
Earnings Per Share
As for profitability, Lantheus Holdings has a trailing twelve months EPS of $6.56.
PE Ratio
Lantheus Holdings has a trailing twelve months price to earnings ratio of 18.15. Meaning, the purchaser of the share is investing $18.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 66.21%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 23%, now sitting on 1.37B for the twelve trailing months.
5. Insight Enterprises (NSIT)
8% sales growth and 17.92% return on equity
Insight Enterprises, Inc. provides information technology hardware, software, and services solutions in the United States, Canada, Europe, the Middle East, Africa, and the Asia-Pacific. It provides solutions to gain insights to network enabled devices, and spots patterns and trends through mass analysis; custom applications to help clients create disruption; custom-developed mobile, cloud, and IoT applications; and custom-developed solutions to help clients review actionable insights within their data, including artificial intelligence for prediction, optimization, cognitive, and vision services. The company also offers various services, such as hybrid cloud, migration and consolidation, workload-platform alignment, converged/hyper converged solutions, and software-defined data center; data platform modernization services; integrated network and security solutions; and consulting, professional, managed, and support services. In addition, it sources, procures, stages, configures, integrates, tests, refurbishes, and redeploys IT products spanning endpoints to infrastructure; and offers software life cycle, and hardware warranty and software maintenance services. Further, the company provides desktop, notebook, tablet, and mobile devices coupled with cloud-based productivity solutions; workplace services, including virtual technical support, remote service desk and automated self-service solutions; and procures, stages, provides, manages, and disposes hardware assets. Additionally, it sells hardware and software products. The company was founded in 1988 and is headquartered in Tempe, Arizona.
Earnings Per Share
As for profitability, Insight Enterprises has a trailing twelve months EPS of $7.95.
PE Ratio
Insight Enterprises has a trailing twelve months price to earnings ratio of 28.33. Meaning, the purchaser of the share is investing $28.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.92%.
6. TriMas Corporation (TRS)
5.5% sales growth and 6.14% return on equity
TriMas Corporation manufactures and provides products for consumer products, aerospace, and industrial end markets worldwide. It operates in three segments: Packaging, Aerospace, and Specialty Products. The Packaging segment offers specialty polymeric and steel closure and dispensing systems, including dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, flexible spouts, and agricultural closures; polymeric jar products; integrated dispensers; bag-in-box products; aseptic closures; industrial closures and flex spouts; and single-bodied and assembled caps and closures under the Rieke, Taplast, Affaba & Ferrari, Stolz, and Rapak brands. The Aerospace segment provides fasteners, collars, blind bolts, rivets, ducting and connectors for air management systems, and machined parts and components to original equipment manufacturers, supply chain distributors, MRO/aftermarket providers, and tier one suppliers for commercial, maintenance, repair, and operations (MRO); and military and defense aerospace applications and platforms under the Monogram Aerospace Fasteners, Allfast Fastening Systems, Mac Fasteners, RSA Engineered Products, and Martinic Engineering brands. The Specialty Products segment offers steel cylinders for use in the transportation, storage, and dispensing of compressed gases under the Norris Cylinder brand; natural gas powered wellhead engines, compressors, and replacement parts for oil and natural gas production, and other industrial and commercial markets under the Arrow brand; and spare parts for various industrial engines. The company sells its products through a direct sales force, third-party agents, and distributors. TriMas Corporation was incorporated in 1986 and is headquartered in Bloomfield Hills, Michigan.
Earnings Per Share
As for profitability, TriMas Corporation has a trailing twelve months EPS of $0.97.
PE Ratio
TriMas Corporation has a trailing twelve months price to earnings ratio of 26.62. Meaning, the purchaser of the share is investing $26.62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.14%.
Yearly Top and Bottom Value
TriMas Corporation’s stock is valued at $25.82 at 01:22 EST, under its 52-week high of $27.89 and way higher than its 52-week low of $22.59.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.4%, now sitting on 905.19M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 6% and 7%, respectively.
